SILS™ Port Laparoscopic Cholecystectomy Post Market Study

May 22, 2017 updated by: Medtronic - MITG

Prospective Randomized Controlled Trial of Traditional Laparoscopic Cholecystectomy Versus SILS™ Port Laparoscopic Cholecystectomy

The objectives of this trial are:

  1. to assess the feasibility and safety of performing SILS™ Port Laparoscopic Cholecystectomy
  2. monitor and compare the outcomes of SILS™ Port Laparoscopic Cholecystectomy versus 4PLC to objectively document the scientific merit and the perceived advantages of SILS™ Port Laparoscopic Cholecystectomy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

202

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rome, Italy
        • Catholic University Of Sacred Heart
      • London, United Kingdom
        • Imperial College, England, St. Mary's Hospital
    • Connecticut
      • New Haven, Connecticut, United States, 06510
        • Yale New Haven Medical Center
    • Florida
      • Tampa, Florida, United States, 33601
        • Tampa General Hospital
    • Illinois
      • Chicago, Illinois, United States, 60611
        • Northwestern Memorial Hospital
    • Massachusetts
      • Boston, Massachusetts, United States, 02111
        • Tufts Medical Center
    • New York
      • Lake Success, New York, United States, 11042
        • North Shore - Long Island Jewish Health System
      • Roslyn, New York, United States, 11576
        • St. Francis Hospital
    • Ohio
      • Cleveland, Ohio, United States, 44106
        • Case Medical Center
    • Texas
      • Dallas, Texas, United States, 75390-8819
        • UT Southwestern Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Between 18 and 85 years old.
  • Patient has a diagnosis of biliary colic with documented gallstones or polyps by imaging or Biliary dyskinesia with documented EF < 30%.
  • Body Mass Index (BMI) < 45 kg/m2.

Exclusion Criteria:

  • Any female patient, who is pregnant, suspected pregnant, or nursing.
  • Any patient with acute calculus or acalculous cholecystitis.
  • Any patient who has had an upper midline or right sub costal incision.
  • Any patient with pre-operative indication for a cholangiogram.
  • Any patient with ASA > 3 with normal liver function.
  • Any patient who is undergoing Peritoneal Dialysis (PD).
  • Any patient who has an unrepaired umbilical hernia or has had prior umbilical hernia repair.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: SILS Port
SILS™ Port Laparoscopic Cholecystectomy
This interventional arm will have a single incision laparoscopic cholecystectomy procedure.
Active Comparator: Four Port
Four Port Laparoscopic Cholecystectomy
This interventional arm will have a traditional four port laparoscopic cholecystectomy procedure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility and Safety of SILS™ Port Cholecystectomy Versus 4PLC
Time Frame: One year
Feasibility and safety as determined by intraoperative and postoperative adverse events.
One year
Operative Time
Time Frame: Day 0
Duration of surgical procedure in minutes.
Day 0
Estimated Blood Loss
Time Frame: Day 0
Blood loss from surgical procedure in cc.
Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average Pain Experienced in the Last 24 Hours at Various Time Frames
Time Frame: Various (Pre-operative, Day 0, 1,3, 5, 1 Week, 2 Week and 1 Month)
Pain evaluation as determined by a 10-point pain intensity numerical rating scale (PI-NRS) ranging from 0 (no pain) to 10 (worst possible pain).
Various (Pre-operative, Day 0, 1,3, 5, 1 Week, 2 Week and 1 Month)
Body Image Scale
Time Frame: Various (1 Week, 2 Week, 1 Month, 3 Month and 1 Year)
The Body Image Scale consists of Questions 1-5 on the Body Image Questionnaire. Here, subjects were asked to answer each question on a scale from 1 to 4 with 1 being the best. Therefore, a total score of 5-20 was calculated for each patient with 5 being the best.
Various (1 Week, 2 Week, 1 Month, 3 Month and 1 Year)
Cosmetic Scale
Time Frame: Various (1 Week, 2 Week, 1 Month, 3 Month and 1 Year)
The Cosmetic Scale consists of Questions 6-8 on the Body Image Questionnaire. Here, patients were asked to answer questions regarding the cosmesis of their own scar (SILS™) or scars (4PLC). The first 2 questions were answered on a scale from 1 to 7 and Question 8 from 1 to 10, both with 1 being the worst. Therefore, a total score of 3-24 was calculated for each patient with 3 being the worst.
Various (1 Week, 2 Week, 1 Month, 3 Month and 1 Year)
Confidence Scale Change From Baseline
Time Frame: Change from Baseline (Pre-Op) at 1 Week, 2 Week, 1 Month, 3 Month and 1 Year

The Confidence Scale consists of Questions 9 and 10 on the Body Image Questionnaire. One question is before procedure and another is after procedure. The Patients were asked to rate their overall confidence before (baseline) and after the procedure. The scores for before/after procedure range from 1 to 10 with 1 being "not very confident" and 10 being "very confident". The score difference from the before/after treatment is compared between the two procedures (4PLC and SILS™)

Here, a positive score indicates that patient confidence has increased.

Change from Baseline (Pre-Op) at 1 Week, 2 Week, 1 Month, 3 Month and 1 Year
Normalized Scar Scores
Time Frame: Various (1 Week, 2 Week, 1 Month, 3 Month and 1 Year)

Photo Series Questionnaire (PSQ). All subjects were asked to score their own scar (Question 1), then rate 2 standardized photos (one of 4PLC scars and one of a SILS™ scar) (Questions 2 and 3, respectively) and finally rate their own scar again after viewing the photos (Question 4). All scars were rated on a scale from 1 to 10 with 10 being the best.

Normalized scores were analyzed for the photo questionnaire. In order to calculate the normalized score, each patient's score of the 4PLC photo was subtracted from their score of their own scar before viewing the photos. the median values were then used to calculate statistical significance.

Normalized Scores of Own Scar are reported below:

Question 1 - Question 2 (Q1 - Q2) Question 4 - Question 2 (Q4 - Q2)

In order to calculate the normalized score for the subject's own scar, Q2 was used as baseline score since Q2 was the score for the conventional procedure 4PLC.

Various (1 Week, 2 Week, 1 Month, 3 Month and 1 Year)
Modified Hollander
Time Frame: Various (1 Week, 2 Week, 1 Month, 3 Month and 1 Year)
Surgeons were asked to answer 6 questions regarding the appearance of their subjects' scars. Each patient's score was summed for a total score 0 to 6 with 0 being the best.
Various (1 Week, 2 Week, 1 Month, 3 Month and 1 Year)
Physical Quality of Life
Time Frame: Various (Baseline (Pre-Op), Day 1, 3, 5 and 1 Week)

SF8 questionnaire was used. This scale measures health and well-being and asks patients to rank their quality of life on a scale of 1 to 5 or a scale of 1 to 6 with 1 being the best and 5 or 6 being the worst. The quality of life questionnaire contains both physical and mental components.

The raw scores are translated into one from 0 to 100, with 0 representing a very low level of QoL and 100 representing a higher QoL.

Various (Baseline (Pre-Op), Day 1, 3, 5 and 1 Week)
Mental Quality of Life
Time Frame: Various (Baseline (Pre-Op), Day 1, 3, 5 and 1 Week)

SF8 scale was used. This scale measures health and well-being and asks patients to rank their quality of life on a scale of 1 to 5 or a scale of 1 to 6 with 1 being the best and 5 or 6 being the worst. The quality of life questionnaire contains both physical and mental components.

The raw scores are translated into one from 0 to 100, with 0 representing a very low level of QoL and 100 representing a higher QoL.

Various (Baseline (Pre-Op), Day 1, 3, 5 and 1 Week)
Time to Cannulization
Time Frame: Day 0
Time required to insert SILS port system or 4 individual ports was captured for each procedure in minutes.
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeffrey Marks, MD, Case Medical Center University Hospitals

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2009

Primary Completion (Actual)

September 1, 2011

Study Completion (Actual)

January 1, 2012

Study Registration Dates

First Submitted

January 29, 2009

First Submitted That Met QC Criteria

January 29, 2009

First Posted (Estimate)

January 30, 2009

Study Record Updates

Last Update Posted (Actual)

December 18, 2017

Last Update Submitted That Met QC Criteria

May 22, 2017

Last Verified

May 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gallbladder Disease

Clinical Trials on SILS™ port laparoscopic cholecystectomy

3
Subscribe